Predicting Clinical Decline and Conversion to Alzheimer’s Disease or Dementia Using Novel Elecsys Aβ(1–42), pTau and tTau CSF Immunoassays
Scientific Reports - United Kingdom
doi 10.1038/s41598-019-54204-z
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2019
Authors
Publisher
Springer Science and Business Media LLC